Trial intelligence / Profile preview

Low-dose ketamine and/or tianeptine as add-on therapy for postoperative pain after hip or knee replacement

MOH_2021-09-01_010237Phase 2Not yet recruiting

Sponsor
פרופ' יורם יובל
Start
Aug 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of ketamine, tianeptine and morphine in postoperative pain (4 arms), sponsored by פרופ' יורם יובל. Planned start Aug 2021; status: not yet recruiting.

02

Drugs

ketaminetianeptinemorphine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on MOH_2021-09-01_010237.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on MOH_2021-09-01_010237.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call